NDC Active Ingredient Adalimumab
Active Ingredient Information
What is Adalimumab?
A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
What is the usage for Adalimumab?
Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).
How many products in the NDC database contain Adalimumab?
The NDC database has 10 products with the active ingredient Adalimumab. The following table lists all the products that have this active ingredient.
NDC Products with Adalimumab
|NDC||Proprietary Name||Non-Proprietary Name||Dosage Form||Route Name||Company Name||Status|
|0074-1115||Proprietary Name:||Adalimumab||Injection, Solution||Abbvie Inc.||ACTIVE|
|0074-1117||Proprietary Name:||Adalimumab||Injection, Solution||Abbvie Inc.||ACTIVE|
|0074-1867||Proprietary Name:||Adalimumab||Liquid||Abbvie Inc.||ACTIVE|
|0074-2330||Proprietary Name:||Adalimumab||Injection, Solution||Abbvie Inc.||ACTIVE|
|55513-400||Proprietary Name: Amjevita||Adalimumab-atto||Injection||Subcutaneous||Amgen Inc||ACTIVE|
|55513-410||Proprietary Name: Amjevita||Adalimumab-atto||Injection||Subcutaneous||Amgen Inc||ACTIVE|
|55513-411||Proprietary Name: Amjevita||Adalimumab-atto||Injection||Subcutaneous||Amgen Inc||ACTIVE|
|58394-051||Proprietary Name:||Adalimumab||Liquid||Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc||ACTIVE|
|71124-0027||Proprietary Name:||Adalimumab||Liquid||Samsung Biologics Co., Ltd.||ACTIVE|
|72511-400||Proprietary Name: Amjevita||Adalimumab-atto||Injection||Subcutaneous||Amgen Usa Inc.||ACTIVE|